Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “overweight” rating reissued by analysts at Cantor Fitzgerald in a research report issued on Thursday, Benzinga reports. They currently have a $7.00 price target on the stock. Cantor Fitzgerald’s price target would suggest a potential upside of 191.67% from the company’s current price. A […]
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) shares gapped up prior to trading on Tuesday . The stock had previously closed at $2.68, but opened at $2.95. Taysha Gene Therapies shares last traded at $3.12, with a volume of 1,228,318 shares trading hands. Analyst Ratings Changes A number of equities analysts have recently […]
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has received an average rating of “Moderate Buy” from the ten research firms that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 […]
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have earned an average rating of “Moderate Buy” from the ten analysts that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average […]
Taysha Gene Therapies, Inc (NASDAQ:TSHA) Receives Average Rating of Moderate Buy from Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.